Ayrıntılar ve konular daha ileri bir tarihte belirlenecek ve programa eklenecektir.

Allergic rhinitis (AR) is a common disease with a recent increasing in prevalence. Traditional treatment strategies of AR, sometimes, show limited effectiveness and side effects. Intranasal injection of Botulinum toxin type A (BTX-A) and multiple postganglionic parasympathectomy of pterygopalatine ganglion (PPG) are among the increasingly used alternative treatment options of AR. Both BTX-A and MSP, in patients with uncontrolled AR, may be a long-lasting therapeutic option for the treatment of nasal hypersecretions, but not as effective as for sneezing and nasal congestion.

Central compartment atopic disease is a subgroup of chronic sinusitis. Here, the symptoms affect the central portion of the nasal airway. Allergy is usually the underlying cause, and treatment may involve antiallergic therapy and, if necessary, limited surgery.